Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-47 (IGHV3-47) is annotated as a pseudogene within the immunoglobulin heavy chain locus in humans, specifically as a member of the IGHV3 subgroup[3][4]. The immunoglobulin heavy-chain locus is composed of multiple variable (VH), diversity (DH), and joining (JH) gene segments, which undergo somatic recombination to generate antibody diversity in B cells[1][2]. However, as a pseudogene, IGHV3-47 does not produce a functional heavy-chain variable region and is not involved in mature antibody expression. Its primary significance is as a marker for genomic studies of antibody gene diversity and evolution but it is not considered a canonical therapeutic target, receptor, enzyme, or protein product.\n\nKey context:\n- This segment is widely listed in genomic databases as a pseudogene and not known to encode a functional, expressed immunoglobulin chain in humans[3][4].\n- As such, it does not have therapeutic relevance and is not associated with known mechanisms of drug action, disease roles, or established biomarkers.\n- The IGHV family as a whole is critical to antibody generation, but IGHV3-47 specifically is non-functional in humans and therefore not a direct target in therapeutic intervention or pharmacology.\n\nDue to this, the entry "immunoglobulin heavy variable 3-47" is not a canonical drug target and has no associated drug mechanism or disease relevance in currently available data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-47 (pseudogene) (IGHV3-47).